Neurodermatitis
Neurodermatitis is a chronic skin condition characterized by intense itching and inflammation, often triggered by stress or irritation. It typically leads to thickened, scaly patches on the skin.
Lichen Simplex Chronicus: Dupilumab Injections
We are studying whether dupilumab injections can help reduce itching in adults with Lichen Simplex Chronicus who haven't found relief from other treatments. The trial will also look at how this treatment affects sleep and overall quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have moderate-to-severe lichen sclerosus (LSC) with significant lesions?
- Have you had lichen sclerosus for at least 6 months?
- Have you tried a strong topical treatment for lichen sclerosus that didn't work in the last 6 months?
- Do you have any other serious skin conditions that might affect your treatment?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Anima
Alken, Belgium
Associatie dermatologie Maldegem
Maldegem, Belgium
Fakultni Nemocnice Bulovka
Dermatovenerologicka klinika
Dolní Chabry, Czechia
Sponsor: Sanofi-Aventis Recherche & Developpement
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.